EUVIMEDEUVIMED entdecken
Crossref

Roxadustat ameliorates vascular calcification in CKD rats by regulating HIF ‐2α/ HIF ‐1α

Yujing Wang iD, Min Xiao, Feng Cai, Yang Li, Tianli Shi, Xiaoyan Zhou, Shuhong Tian, Denggao Huang iD

Environmental Toxicology · 2024-04 · 39 (4) · 2363-2373

DOI: 10.1002/tox.24116 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Environmental Toxicology, online erschienen am 29.12.2023. Verfasst von Yujing Wang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hemodialysis, Haikou Affiliated Hospital of Central South University Xiangya School of Medicine, Haikou, China. Hauptthemen laut MEDLINE: Vascular Calcification, Renal Insufficiency, Chronic. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 34 Literaturangaben. Gefördert von: Hainan Province Science and Technology Special Fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Vascular calcification (VC) is a common complication of chronic kidney disease (CKD). VC is a gene‐regulated process similar to osteogenic differentiation. There are still no convincing schemes to prevent and reduce the development of VC. It has been reported that hypoxia‐inducing factor 1α (HIF‐1α) and endothelin‐1(ET‐1) are related to VC. In this study, we found that the expression of ET‐1 and HIF‐1α was enhanced after VC, the interaction between HIF‐1α and ET‐1 was confirmed by CO‐IP and luciferase experiments. We found that ET‐1 was an upregulated differential gene of calcified vascular smooth muscle cells (VSMCs) through gene sequencing. However, hypoxia‐inducing factor 2α (HIF‐2α) and HIF‐1α have antagonistic effects on each other. HIF‐1α is a pro‐inflammatory cytokine, and HIF‐2α can improve inflammation and fibrosis. Roxadustat, as a selective PHD3 inhibitor, preferentially activates HIF‐2α. It is still unclear whether roxadustat improves VC in CKD by regulating the expression of HIF‐2α/HIF‐1α. Alizarin red staining and western blot as well as immunohistochemical results showed that roxadustat could significantly reduce the degree of vascular and VSMCs calcification in CKD rats. Serum HIF‐1α and ET‐1 were significantly decreased after roxadustat treatment. In addition, western blot results showed that roxadustat could decrease the expression of HIF‐1α and ET‐1 in vascular tissues and calcified VSMC, but HIF‐2α expression significantly increased. Interestingly, our study confirmed that activation of HIF‐1α or inhibition of HIF‐2α reversed the ameliorating effect of roxadustat on VC, proving that the effect mediated by roxadustat is HIF‐2α/HIF‐1α dependent. We have demonstrated for the first time that roxadustat improves VC in CKD rats by regulating HIF‐2α/HIF‐1α, thus providing a new idea for the application of roxadustat in VC of CKD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Vascular CalcificationRenal Insufficiency, ChronicRatsAnimalsOsteogenesisHypoxiaBasic Helix-Loop-Helix ProteinsHypoxia-Inducible Factor 1, alpha Subunit

Stichwörter der Autor:innen

endothelin-1hypoxia-inducing factor 1αhypoxia-inducing factor 2αroxadustatvascular calcification

Substanzen

Basic Helix-Loop-Helix ProteinsHypoxia-Inducible Factor 1, alpha Subunit

Autor:innen und Institutionen

  • Department of Hemodialysis, Haikou Affiliated Hospital of Central South University Xiangya School of Medicine, Haikou, China.
  • Department of Clinical Laboratory, Strategic Support Force Medical Center, Beijing, China.
  • Department of Scientific Research, Haikou Affiliated Hospital of Central South University Xiangya School of Medicine, Haikou, China.
  • Department of Nephrology, Haikou Affiliated Hospital of Central South University Xiangya School of Medicine, Haikou, China.
  • Research Center for Drug Safety Evaluation of Hainan Province, Hainan Medical University, Haikou, China.
  • Department of Central Laboratory, Haikou Affiliated Hospital of Central South University Xiangya School of Medicine, Haikou, China.

ORCID-Profile: Yujing Wang, Denggao Huang

Förderung

  • Hainan Province Science and Technology Special Fund

Zitieren

APA

Wang, Y., Xiao, M., Cai, F., Li, Y., Shi, T., Zhou, X., Tian, S., & Huang, D. (2024). Roxadustat ameliorates vascular calcification in CKD rats by regulating HIF ‐2α/ HIF ‐1α. Environmental Toxicology, 39(4), 2363-2373. https://doi.org/10.1002/tox.24116

Vancouver

Wang Y, Xiao M, Cai F, Li Y, Shi T, Zhou X, et al. Roxadustat ameliorates vascular calcification in CKD rats by regulating HIF ‐2α/ HIF ‐1α. Environmental Toxicology. 2024;39(4):2363-2373. doi:10.1002/tox.24116

BibTeX
@article{Wang2024,
  author = {Wang, Yujing and Xiao, Min and Cai, Feng and Li, Yang and Shi, Tianli and Zhou, Xiaoyan and Tian, Shuhong and Huang, Denggao},
  title = {Roxadustat ameliorates vascular calcification in CKD rats by regulating HIF ‐2α/ HIF ‐1α},
  journal = {Environmental Toxicology},
  year = {2024},
  volume = {39},
  number = {4},
  pages = {2363--2373},
  doi = {10.1002/tox.24116}
}
Kostenlos starten →